Infectious diarrhea could soon be not so infectious with confirmation from biotech company Immuron (ASX: IMC) that the first patients have enrolled for their Phase 2 clinical trial seeking to address issues that arise from unpleasant episodes. The trial is a response to the persistent challenge of infectious diarrhea among travellers and military personnel deployed
Read More
During November the market consensus shifted towards the FOMC and ECB remaining on hold throughout 2024. This reflects a forecast that inflation will continue to deflate while unemployment remains low, and the economy keeps growing but at a slow pace. This is the “Goldilocks” scenario. The alternative view is that inflation will begin to rise
Read More
Precision microbiome company Microba (ASX: MAP) and the US-based F&B company International Flavors & Fragrances (IFF) have entered the second phase of their joint research initiative, aiming to develop novel microbiome-based treatments for various allergies. The collaboration, a strategic move within the bioscience and health sectors, signals a step forward in addressing the need for
Read More
Quickly becoming the go-to supplier of critical data within the global wagering industry, RAS Technology (ASX: RTH) has been engaged by Playbook Engineering, a leading UK-based platform provider, for wagering technology, racing data, and editorial content for Playbook’s diverse portfolio of sportsbook brands. The 3-year contract is expected to be valued at $800k per annum
Read More
After becoming a member of the US CLAWS hub in October 2023, semiconductor developer BluGlass (ASX: BLG) has signed its first contract: a $2.6 million (US$1.775m) contract with North Carolina State University (NCSU) to develop lasers in FY24. As part of its contract for FY24, BluGlass is working on single-frequency DFB (Distributed-feedback) lasers and progressing
Read More
In the midst of a debt dispute with a major lender, Australian security technology company Electro Optic Systems (ASX: EOS), which operates in the defence and space sectors, has announced a robust revenue projection for the calendar year 2023. The Company anticipates its revenue to range between $210 million and $230 million for CY23. This
Read More
HealthTech company Advanced Health Intelligence (ASX: AHI) is set to launch a medically-approved mobile phone-based atrial fibrillation (AF) assessment in Q2 CY24 in collaboration with Belgium-based Qompium NV, a company specialising in mobile scanning tech. Globally, there are about 60 million cases of atrial fibrillation (AF), which is a form of arrhythmia involving irregular heartbeat.
Read More
Derived from the roots of the Piper methysticum plant native to the Pacific Islands, Kava has gained popularity for its potential health benefits as evidenced by The Calmer Co (ASX: CCO), which reported $110,000 in sales through the month of November for it’s eCommerce channels. These sales primarily came from The Calmer Co’s online Shopify
Read More
Over the years, the Australian cannabis market has consistently posted revenue growth and is expected to be valued at $1.1 billion by 2028. Both Aussies and Europeans are big consumers of cannabis, making them attractive markets for medical cannabis companies like Little Green Pharma (ASX: LGP). Little Green Pharma posted a 37% revenue spike to
Read More
National power and communications infrastructure provider GenusPlus (ASX: GNP) has secured three contracts in collaboration with Samsung C&T Corporation. These contracts with the Melbourne Renewable Energy Hub (MREH) include the engineering, procurement, construction, and commissioning of the Balance of Plant scope (i.e. the supporting components of a power plant), as well as the installation of
Read More
